The untapped power of multivariate analysis for target identification in cancer drug discovery
Discover how multivariate analysis is transforming target identification in cancer drug discovery by moving beyond traditional methods.
About
Sudha is an ex-molecular biologist turned healthcare consultant and freelance science writer, based out of Singapore. Aside from serving as a good stress-buster, her writing helps her keep abreast of the latest scientific technologies. In her spare time, she is a wildlife enthusiast, portrait artist and a history buff. Find her work here: bit.ly/3tVdtM3
Articles by Sudha Sundaram
Powering up biologics development using mammalian cell lines
Explore how mammalian cell lines drive biopharmaceutical innovation, acting as mini-factories for vital biotherapeutics and vaccines.
Mastering biologics tech transfer: key success factors
Unlock the secrets of efficient tech transfers for biologics, and explore critical stages and success factors.
Optimizing early discovery by unraveling cancer complexity within precision therapeutics
Nurturing healthcare innovation: a multi-disciplinary ecosystem to overcome startup challenges
The Covid-19 pandemic highlighted the importance of innovation in the healthcare space when tackling a public health challenge. Nonetheless, health innovation startups today face multiple hurdles, from sourcing funding, to obtaining access to the right expertise, and more. Of late, an additional hurdle that young life science businesses also have to contend with is the […]
Impacting vaccine development: COVID-19 and its implications for the future of vaccines
The development of COVID-19 vaccines was an unprecedented achievement at a time of urgent medical need. We explore the novel technology platforms that went into their development and consider their long-term impact on vaccine research. Ever since the first vaccine against smallpox in the late 1700s, vaccines have gained a reputation as a critical tool […]
ADVERTISEMENT
ADVERTISEMENT
The organoid era: bringing patient-relevant preclinical models to the lab
Drug development is a lengthy and costly process that takes at least 10 years on average from drug discovery to commercialization, requiring billions of dollars in investment. However, over 90% of new drugs that are tested in clinical trials fail. Organoids — three-dimensional, patient-derived mini-organs in a dish — offer a solution to this challenge. […]
Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO
Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in process development, optimization, and scale-up. In this article, we share an exclusive sneak-peek into a recent survey, which explores the main reasons why biotech companies collaborate with CDMOs at different stages of drug development. To make a new drug candidate […]
How to Make Cell Culture Expansion Easy
Cell culture expansion for biotherapeutic development has traditionally involved a series of time-consuming, labor-intensive batch cultures that are susceptible to contamination. Cell culture expansion using a perfusion process promises easy scalability, ensures high productivity gains, and saves time and costs during large-scale biomanufacturing. Cell culture is a crucial tool in the biotech sector. Applications range […]
Stem Cell-based Cultured Meat: No Longer Science Fiction
Since the turn of the century, stem cell technology has delivered on its promise to transform the healthcare industry, while its applications across different sectors have continued to emerge. Bioreactors, offering improved process control as well as scalability, have been adopted worldwide for stem cell production and cultivation. Join us as we dive into the […]
ADVERTISEMENT
